Chronic Daily Headache

Total Page:16

File Type:pdf, Size:1020Kb

Chronic Daily Headache Chronic daily headache The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Spierings, Egilius L. H. 2003. Chronic daily headache. The Journal of Headache and Pain 4(3): 111-124. Published Version doi:10.1007/s10194-003-0045-6 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10579386 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA J Headache Pain (2003) 4:111–124 DOI 10.1007/s10194-003-0045-6 REVIEW Egilius L.H. Spierings Chronic daily headache Received: 5 March 2003 Abstract Chronic daily headache opioids in intractable patients. The Accepted in revised form: 16 April 2003 relates to the daily or almost daily review concludes with a discussion occurrence of headache in a non- of hemicrania continua, an paroxysmal pattern. In this review, I indomethacin-responsive headache discuss the presentation, develop- syndrome. ment, outcome, and treatment of chronic daily headache. In the con- Key words Daily headache • text of the development of chronic Chronic daily headache • E.L.H. Spierings (౧) daily headache, a headache continu- Presentation • Development • Department of Neurology, um is presented along with its under- Tension-type headache • Migraine • Brigham and Women’s Hospital, Harvard Medical School, lying pathophysiology. The treatment Headache continuum • Outcome • Boston, Massachusetts, USA section covers rebound headache, Treatment • Rebound headache • Tel.: +1-781-431-1118 analgesic and vasoconstrictor with- Hemicrania continua Fax: +1-781-431-0180 drawal, and the use of long-acting ble, to distinguish from chronic daily headache on the basis Introduction of its presentation alone. It differs from chronic daily headache in the somewhat more consistent and less variable Chronic daily headache refers to the daily or almost daily intensity of the headache and in the absolute response to occurrence of headache. However, not all daily or almost preventive treatment with indomethacin. daily headaches fall under this denominator, as is the case with the daily or almost daily headaches of (chronic) cluster headache and (chronic) paroxysmal hemicrania. These con- ditions are referred to as paroxysmal daily headaches, in Presentation which the headaches occur in well-defined attack patterns. In cluster headache, the attack pattern is that of headaches In a study of 258 patients from my private headache practice occurring once or twice per day, lasting for one-half to 2 with chronic daily headache, defined as headaches occurring hours; in paroxysmal hemicrania, it is that of headaches at least 5 days per week for at least 1 year, my colleagues occurring 5–15 times per day, lasting for 10–30 minutes. and I characterized the presentation of the headache condi- Of the non-paroxysmal daily headaches, hemicrania tion [1]. We excluded only those patients with daily continua is a condition that does not fall under the denomi- headaches who described well-established paroxysmal nator of chronic daily headache either. However, it is dis- headache syndromes, in order to capture as much of the clin- cussed in this review because it is difficult, if not impossi- ical features of the condition as possible. Of the 258 112 patients, 19% were men and 81% women; their average age terns. The most common pattern is that in which the at the time of consultation was 42 years. The distribution of headaches gradually increase in intensity as the day pro- the age at onset of (any) headache for the men and women gresses, to be worst in the afternoon or evening. According separately is shown in Fig. 1: 77% of all patients (69% of to the results of the study, this is the pattern in more than half men and 79% of women) experienced the onset of headache of the patients with chronic daily headache. The less com- before the age of 30 years. The onset of headache occurred mon pattern, which I refer to as the “reversed diurnal pat- in the second decade of life in 36% of the women, as tern”, is that in which the headaches are worst on awakening opposed to 24% of the men. The peak of headache onset in in the morning and gradually improve as the day progresses. the second decade in women is indicative of the importance This was the case in one-quarter of the patients while in the of the menstrual cycle in the development of headache in remaining quarter, the diurnal course of the headaches was women. variable. With regard to diurnal pattern, the daily headaches were The reversed diurnal pattern is associated with the present on awakening or came on in the course of the morn- most frequent nighttime awakenings with headache. In ing in 79% of the patients, came on in the afternoon or the study, nocturnal awakening by headache occurred at evening in 6%, and had a variable time of onset in 15% (Fig. least once per week in 36% of the patients. Of the patients 2). In 25%, the headaches were worst on awakening or in the who were woken up by headache at least once per week, course of the morning; in 53% they were worst in the after- 48% experienced the worst headache on awakening or in noon or evening, and in 22% they were worst at a variable the course of the morning, as opposed to 22% of the time of the day. The results agree with my clinical observa- patients who were woken up by headache less than once tion that daily headaches come in two distinct diurnal pat- per week. Fig. 1 Age at onset of (any) headache, by gender (n=251). (From [1] with permission) Fig. 2 Diurnal pattern of the daily headaches (n=214). (From [1] with permission) 113 With regard to associated symptoms, the daily headaches chronic daily headache who seek specialty care for their were at least twice per week associated with nausea in 35% headaches do not have chronic tension-type headache. They and with vomiting in 9%. With regard to the laterality of the have chronic tension-type headache combined with migraine daily headaches, 36% were unilateral, 50% bilateral, and or, as I prefer to call it, tension-type vascular headache. This 14% either unilateral or bilateral. The unilateral headaches conclusion is based on the view that, with regard to clinical had a fixed lateralization in 83% and alternated between the presentation, intensity is the predominant distinguishing fea- left and right sides in 17%. The aggravating factors of the ture between migraine and tension-type headache. daily headaches are shown in Table 1. Apart from light and With regard to laterality, the severe headaches were uni- noise, most common were physical activity, bending over, lateral in 43%, bilateral in 42%, and either unilateral or stress or tension, and menstruation. bilateral in 15%. The unilateral headaches had a fixed later- Overall, 94% of the patients experienced severe alization in 79% and alternated between the left and right headaches in addition to the daily headaches (Fig. 3). sides in 21%. One would expect the severe headaches to be Twenty-six percent of the patients experienced severe lateralized more often than the daily headaches, but this was headaches more than 15 days per month, while the majority not the case. With regard to associated symptoms, the severe (63%) experienced severe headaches 10 days per month or headaches were at least twice per month associated with less. The results suggest that the majority of the patients with nausea in 76% and with vomiting in 38%. In the development of chronic daily headache, medica- Table 1 Aggravating factors of the daily headaches (n=258). (From tion intake is considered to play an important role, in partic- [1] with permission) ular the intake of analgesic and vasoconstrictor medications [2]. A widely used vasoconstrictor for the abortive treatment Patients, % of headache is caffeine, in beverages, especially coffee, but Light 40 also in prescription and non-prescription medications. Physical activity 33 Therefore, we measured the caffeine intake of our patients Bending over 33 with chronic daily headache, by looking at their coffee and Noise 30 medication intakes. A cup of coffee was considered to con- Stress or tension 29 tain 100 mg caffeine. We found that 43% of the patients used Menstruationa 28 less than 100 mg caffeine per day, 35% between 100 and Alcohol 20 300 mg, and 22% more than 300 mg. The average caffeine Coughing or sneezing 15 intake was 170 mg per day, which is approximately the Foods or drinks 13 equivalent of two cups of coffee. This is less than what was Lack of sleep 12 found in the population of Sydney, Australia, where the Not eating on time 11 Straining 10 average caffeine intake was 240 mg per day, with 30% con- Weather changes 10 suming more than 300 mg [3]. Exhaustion 10 With regard to analgesic use, we only considered the non-opioid medications because opioids were hardly used a For women only; n=208 by the patients for the treatment of headaches. Furthermore, Fig. 3 Frequency of severe headaches in days per month (n=197). (From [1] with permission) 114 of the barbiturate-containing medications, we did not take abrupt onset of the daily headaches and 145 (81%) a grad- into account the barbiturate component because it is not ual onset. The distribution of the age at onset of the daily strictly an analgesic. With these limitations, we found that headaches in those patients with abrupt-onset secondary 26% of the patients used less than 500 mg aspirin-equiva- chronic daily headache is shown in Fig.
Recommended publications
  • Cluster Headache: a Review MARILYN J
    • Cluster headache: A review MARILYN J. CONNORS, DO ID Cluster headache is a debilitat­ consists of episodes of excruciating facial pain that ing neuronal headache with secondary vas­ is generally unilateraP and often accompanied by cular changes and is often accompanied by ipsilateral parasympathetic phenomena including other characteristic signs and symptoms, such nasal congestion, rhinorrhea, conjunctival injec­ as unilateral rhinorrhea, lacrimation, and con­ tion, and lacrimation. Patients may also experi­ junctival injection. It primarily affects men, ence complete or partial Horner's syndrome (that and in many cases, patients have distinguishing is, unilateral miosis with normal direct light response facial, body, and psychologic features. Sever­ and mild ipsilateral ptosis, facial flushing, and al factors may precipitate cluster headaches, hyperhidrosis).4-6 These autonomic disturbances including histamine, nitroglycerin, alcohol, sometimes precede or occur early in the headache, transition from rapid eye movement (REM) adding credence to the theory that this constella­ to non-REM sleep, circadian periodicity, envi­ tion of symptoms is an integral part of an attack and ronmental alterations, and change in the level not a secondary consequence. Some investigators of physical, emotional, or mental activity. The consider cluster headache to exemplify a tempo­ pathophysiologic features have not been com­ rary and local imbalance between sympathetic and pletely elucidated, but the realms of neuro­ parasympathetic systems via the central nervous biology, intracranial hemodynamics, endocrinol­ system (CNS).! ogy, and immunology are included. Therapy The nomenclature of this form of headache in is prophylactic or abortive (or both). Treat­ the literature is extensive and descriptive, includ­ ment, possibly with combination regimens, ing such terminology as histamine cephalgia, ery­ should be tailored to the needs of the indi­ thromelalgia of the head, red migraine, atypical vidual patient.
    [Show full text]
  • Acupressure for Tension Headache
    MANUAL THERAPY Malissa Martin, EdD, ATC, CSCS, Report Editor Acupressure for Tension Headache Sandra Hendrich, PT, DPT; Leamor Kahanov, EdD, LAT, ATC; and Lindsey E. Eberman, PhD, LAT, ATC • Indiana State University Tension headache (TH) or “stress head- milder severity and longer duration and is ache” is the most common type of headache generally described as a feeling of tightness occurring among adults, occurring twice as or a band-like pressure felt around the back often in women as in men, and a leading of the neck or the head or in the forehead health complaint.1,2,3 Exercise-related head- region.1-4 The pain associated with TH is usu- aches are one of the ally dull in nature and generally occurs on most common medical both sides of the head. Tight muscles in the Key PPointsoints problems affecting ath- neck, shoulders, upper back, and temporal Addressing three key acupressure points letes, with up to 50% regions, often accompanied by stress, may (temporal, base of the skull, first dorsal reporting headache as be an indication that myofacial trigger points 1-4 interossi) may reduce or eliminate tension a regular consequence (MTPs) are a cause of TH. headache symptoms. of athletic participa- Treatment may include psychological tion.4 A majority (72%) counseling, manual therapy, physiologic Accupressure points (i.e., Joining of the of these athletes report intervention, and pharmaceutical treat- Valleys, LI4; Gates of Consciousness, that neither trauma or ment.1,3 An association between MTPs and GB20; and the temporal region) may be concussion is the cause, TH has been identified, with treatment ame- specific to tension headaches but may also and therefore, such liorating or eliminating symptoms.2,3 MTPs be hypersensitive muscles delineated by a headaches can be cat- in the upper trapezius, sternocleidomastoid taut band of tissues.
    [Show full text]
  • Migraine; Cluster Headache; Tension Headache Order Set Requirements: Allergies Risk Assessment / Scoring Tools / Screening: See Clinical Decision Support Section
    Provincial Clinical Knowledge Topic Primary Headaches, Adult – Emergency V 1.0 © 2017, Alberta Health Services. This work is licensed under the Creative Commons Attribution-Non-Commercial-No Derivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Disclaimer: This material is intended for use by clinicians only and is provided on an "as is", "where is" basis. Although reasonable efforts were made to confirm the accuracy of the information, Alberta Health Services does not make any representation or warranty, express, implied or statutory, as to the accuracy, reliability, completeness, applicability or fitness for a particular purpose of such information. This material is not a substitute for the advice of a qualified health professional. Alberta Health Services expressly disclaims all liability for the use of these materials, and for any claims, actions, demands or suits arising from such use. Revision History Version Date of Revision Description of Revision Revised By 1.0 March 2017 Topic completed and disseminated See Acknowledgements Primary Headaches, Adult – Emergency V 1.0 Page 1 of 16 Important Information Before You Begin The recommendations contained in this knowledge topic have been provincially adjudicated and are based on best practice and available evidence. Clinicians applying these recommendations should, in consultation with the patient, use independent medical judgment in the context of individual clinical circumstances to direct care. This knowledge topic will be reviewed periodically and updated as best practice evidence and practice change. The information in this topic strives to adhere to Institute for Safe Medication Practices (ISMP) safety standards and align with Quality and Safety initiatives and accreditation requirements such as the Required Organizational Practices.
    [Show full text]
  • Headache: General Considerations CQ I-1
    I Headache: General Considerations CQ I-1 How is headache classified and diagnosed? Recommendation Headache should be classified and diagnosed according to the International Classification of Headache Disorders 3rd edition (beta version). Grade A Background and Objective In 2004, the International Headache Society (IHS) revised the first edition of the IHS guideline for the first time in 15 years, incorporating the latest advances in research, evidence and criticisms. The resulting document, International Classification of Headache Disorders 2nd Edition (ICHD-2) was published in Cephalalgia.1) In the same year, the ICHD-2 was translated into Japanese and published.2) From 2004, headache should be classified and diagnosed in accordance with the ICHD-2. The first recorded classification of headache was by Aretaeus (a physician born in 81 BC) of Cappadacia in the present day Turkey, who classified headaches into cephalalgia, cephalea, and heterocrania.3)-5) Heterocrania was described as “half head” headache, which is equivalent to migraine in the present day classification. The first consensus-orientated headache classification in history was the classification by the Ad Hoc Committee on Classification of Headache of the American Neurological Association (Ad Hoc classification) published in 1962.6) In this classification, headache was classified into 15 types, but no diagnostic criteria were included. In 1988, the Headache Classification Committee of the International Headache Society chaired by Olesen proposed the first international classification of headache disorders (IHS Classification,st 1 edition, 1988).7) The IHS Classificationst 1 edition first classified headache into 13 items, and further subdivided into 165 headache types. For each subtype, operational criteria were described.
    [Show full text]
  • Headache in Primary Care *
    HeadacHe IN PRIMARY CARE * Dr Neil Whittaker - GP, Nelson Key Advisers: Dr Alistair Dunn - GP, Whangarei Dr Alan Wright - Neurologist, Dunedin Expert Reviewer: Every headache presentation is unique and challenging, requiring a flexible and individualised approach to headache management. - Most headaches are benign primary headaches - A few headaches are secondary to underlying pathology, which may be life threatening Primary headaches can be difficult to diagnose and manage. People, who experience severe or recurrent primary headache, can be subject to significant social, financial and disability burden. We cannot cover all the issues associated with headache presentation in primary care; instead, our focus is on assisting clinicians to: - Recognise presentations of secondary headaches - Effectively diagnose primary headaches - Manage primary headaches, in particular tension-type headache, migraine and cluster headache - Avoid, recognise and manage medication overuse headache 10 I BPJ I Issue 7 www.bpac.org.nz keyword: “Headache” DIAGNOSIS OF HEADACHE IN PRIMARY CARE The keys to headache diagnosis in primary care are: - Ensuring occasional presentations of secondary headache do not escape notice - Differentiating between the causes of primary headache - Addressing patient concerns about serious pathology RECOGNISE SERIOUS SECONDARY HEADACHES BY BEING ALERT FOR RED FLAGS AND PERFORMING FUNDOSCOPY Although primary care clinicians worry about Red Flags in headache presentation missing serious secondary headaches, most Red Flags in headache presentation include: people presenting with secondary headache will have alerting clinical features. These Age clinical features, red flags, are not highly - Over 50 years at onset of new headache specific but do alert clinicians to the need for - Under 10 years at onset particular care in the history, examination and Characteristics investigation.
    [Show full text]
  • Headache: a Patient's Guide (Pdf)
    Headache A Patient’s Guide Kathleen Digre, MD • Susan Baggaley, APRN • K.C. Brennan, MD • Seniha Ozudogru, MD 729 Arapeen Drive Salt Lake City, Utah 84108 801.585.7575 headache.uofuhealth.org Headache: A Patient’s Guide eadache is an extremely common problem. It is estimated that 10-20% of all people have migraine. Headache is one of the most common reasons H people visit the doctor’s office. Headache can be the symptom of a serious problem, or it can be recurrent, annoying and disabling, without any underlying structural cause. WHAT CAUSES HEAD PAIN? Pain in the head is carried by certain nerves that supply the head and neck. The trigeminal system impacts the face as well as the cervical (neck) 1 and 2 nerves in the back of the head. Although pain can indicate that something is pushing on the brain or nerves, most of the time nothing is pushing on anything. We think that in migraine there may be a generator of headache in the brain which can be triggered by many things. Some people’s generators are more sensitive to stimuli such as light, noise, odor, and stress than others, causing a person to have more frequent headaches. THERE ARE MANY TYPES OF HEADACHES! Most people have more than one type of headache. The most common type of headache seen in a doctor's office is migraine (the most common type of headache in the general population is tension headache). Some people do not believe that migraine and tension headaches are different headaches, but rather two ends of a headache continuum.
    [Show full text]
  • The Migraine-Epilepsy Syndrome
    medigraphic Artemisaen línea Arch Neurocien (Mex) Vol 11, No. 4: 282-287, 2006 The Migraine- Epilepsy Syndrome Arch Neurocien (Mex) Vol. 11, No. 4: 282-287, 2006 Artículo de revisión ©INNN, 2006 de caso The migraine-epilepsy syndrome Enrique Otero Siliceo†, Fernando Zermeño EL SINDROME MIGRAÑA-EPILEPSIA represent a neural exitation. Since that the glutamate has in important rol in both patologys depending of the part of the brain more affected the symptoms might RESUMEN vary from visual to abdominal phemomena. La migraña y la epilepsia tienen varios puntos en común Key words: migraine epilepsy, EEG abnormalities, sintomática clínica y genéticamente lo que ha sido glutamate, diagnosis. postulado por más de cien años. El fenómeno referido como migraña-epilepsia sugiere que exista una he first steps of a practical, approach by patofisiología común. El síndrome de migraña o physicians in recognizing and treating neuro- epilepsia tiene fenómenos comunes de dolor adominal T logic diseases are to recognithat there are jaqueca anormalidades del EE y respuesta a droga various overlaps between migraine and epilepsy. antiepilépticas. En ocasiones el paciente puede tener Epileptic seizures and classic migraine episodes may un ataque migrañoso o una convulsión o en otras occur in the same patient. Migraine and epilepsy share ambas. La comorbilidad puede explicarse por estados several genetic, clinical, evolutive and neurophysio- de hiperrexcitabilidad neural. Alteraciones electroen- logic features. A relationship between epilepsy and cefalográficas son comunes en estos estados. En migraine has been postulated for over a hundred years apariencia el glutamato tiene un papel importante tanto and the syndrome of Migraine-Epilepsy illustrates this en la migraña como en la epilepsia.
    [Show full text]
  • Migraine: Current Concepts and Emerging Therapies
    Vascular Pharmacology 43 (2005) 176 – 187 www.elsevier.com/locate/vph Migraine: Current concepts and emerging therapies D.K. Arulmozhi a,b,*, A. Veeranjaneyulu a, S.L. Bodhankar b aNew Chemical Entity Research, Lupin Research Park, Village Nande, Taluk Mulshi, Pune 411 042, Maharashtra, India bDepartment of Pharmacology, Bharati Vidyapeeth, Poona College of Pharmacy, Pune 411 038, Maharashtra, India Received 23 April 2005; received in revised form 17 June 2005; accepted 11 July 2005 Abstract Migraine is a recurrent incapacitating neurovascular disorder characterized by attacks of debilitating pain associated with photophobia, phonophobia, nausea and vomiting. Migraine affects a substantial fraction of world population and is a major cause of disability in the work place. Though the pathophysiology of migraine is still unclear three major theories proposed with regard to the mechanisms of migraine are vascular (due to cerebral vasodilatation), neurological (abnormal neurological firing which causes the spreading depression and migraine) and neurogenic dural inflammation (release of inflammatory neuropeptides). The modern understanding of the pathogenesis of migraine is based on the concept that it is a neurovascular disorder. The drugs used in the treatment of migraine either abolish the acute migraine headache or aim its prevention. The last decade has witnessed the advent of Sumatriptan and the Ftriptan_ class of 5-HT1B/1D receptor agonists which have well established efficacy in treating migraine. Currently prophylactic treatments for migraine include calcium channel blockers, 5-HT2 receptor antagonists, beta adrenoceptor blockers and g-amino butyric acid (GABA) agonists. Unfortunately, many of these treatments are non specific and not always effective. Despite such progress, in view of the complexity of the etiology of migraine, it still remains undiagnosed and available therapies are underused.
    [Show full text]
  • Migraine: Spectrum of Symptoms and Diagnosis
    KEY POINT: MIGRAINE: SPECTRUM A Most patients develop migraine in the first 3 OF SYMPTOMS decades of life, some in the AND DIAGNOSIS fourth and even the fifth decade. William B. Young, Stephen D. Silberstein ABSTRACT The migraine attack can be divided into four phases. Premonitory phenomena occur hours to days before headache onset and consist of psychological, neuro- logical, or general symptoms. The migraine aura is comprised of focal neurological phenomena that precede or accompany an attack. Visual and sensory auras are the most common. The migraine headache is typically unilateral, throbbing, and aggravated by routine physical activity. Cutaneous allodynia develops during un- treated migraine in 60% to 75% of cases. Migraine attacks can be accompanied by other associated symptoms, including nausea and vomiting, gastroparesis, di- arrhea, photophobia, phonophobia, osmophobia, lightheadedness and vertigo, and constitutional, mood, and mental changes. Differential diagnoses include cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoenphalopathy (CADASIL), pseudomigraine with lymphocytic pleocytosis, ophthalmoplegic mi- graine, Tolosa-Hunt syndrome, mitochondrial disorders, encephalitis, ornithine transcarbamylase deficiency, and benign idiopathic thunderclap headache. Migraine is a common episodic head- (Headache Classification Subcommittee, ache disorder with a 1-year prevalence 2004): of approximately 18% in women, 6% inmen,and4%inchildren.Attacks Recurrent attacks of headache, consist of various combinations of widely varied in intensity, fre- headache and neurological, gastrointes- quency, and duration. The attacks tinal, and autonomic symptoms. Most are commonly unilateral in onset; patients develop migraine in the first are usually associated with an- 67 3 decades of life, some in the fourth orexia and sometimes with nausea and even the fifth decade.
    [Show full text]
  • A Characteristic Ganglioside Antibody Pattern in the CSF of Patients With
    Journal ofNeurology, Neurosurgery, and Psychiatry 1993;56:361-364 361 A characteristic ganglioside antibody pattern in J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.56.4.361 on 1 April 1993. Downloaded from the CSF of patients with amyotrophic lateral sclerosis Andreas Stevens, Michael Weller, Horst Wietholter Abstract Materials and methods Paired cerebrospinal fluid and serum Thirty five patients with amyotrophic lateral samples of patients with amyotrophic sclerosis, 16 men and 19 women, mean age lateral sclerosis (n = 35) revealed no con- 53-5 (2 4) years, range 25-79 years at diag- sistent abnormalities of CSF cell count, nosis, without a family history of the illness, CSF albumin, CSF IgG, CSF IgM, IgG were included in this study. The diagnosis or IgM index, or oligoclonal immuno- was clinical and based on the presence of globulin band formation in the CSF. both upper and lower motor neuron symp- Determination of IgG and IgM CSF and toms and signs. Eight patients had prominent serum antibodies to gangliosides GM1, bulbar signs, 31 had definite spasticity. For GM2, GM3, AGMI, GDla, GDlb, and inclusion in this study, the onset of symptoms GTlb showed a characteristic pattern had to be insidious and not started before the which allowed the differentiation of age of 20. The clinical course had to be amyotrophic lateral sclerosis from con- progressive. Specific attention was given to trols and from patients with other neuro- alternative diagnoses of cervical spondylosis, logical disorders including multiple neoplastic lesions of cervical spinal cord sclerosis. Specifically, patients with the and brain stem, polymyositis, peripheral disease had elevated CSF IgM antibodies neuropathy, progressive muscle atrophy, to all gangliosides except AGMI.
    [Show full text]
  • Tension-Type Headache CQ III-1
    III Tension-type headache CQ III-1 How is tension-type headache classified? Recommendation Since 1962, various classifications for tension-type headache have been proposed. Currently, classification according to the International Classification of Headache Disorders 3rd Edition (beta version) (ICHD-3beta) published in 2013 is recommended. Grade A Background and Objective Diagnostic classification that forms the basis of guidelines is certainly important for formulating clinical care and treatment policies. The ICHD-3beta is not simply a document based on classification, it also addresses diagnosis and treatment scientifically and practically from all aspects. Comments and Evidence The classification of tension-type headache (TTH) is provided by the International Classification of Headache Disorders 3rd edition beta version (ICHD-3beta).1)2) The division of tension-type headache into episodic and chronic types adopted by the first edition of the International Classification of Headache Disorders (1988)3) is extremely useful. The International Classification of Headache Disorders 2nd edition (ICHD-II) further subdivides the episodic type according to frequency, and states that this is based on the difference in pathophysiology. The former episodic tension-type headache (ETTH) is further classified into 2.1 infrequent episodic tension-type headache (IETTH) with headache episodes less than once per month (<12 days/year), and 2.2 frequent episodic tension-type headache (FETTH) with higher frequency and longer duration (<15 days/month). The infrequent subtype has little impact on the individual, and to a certain extent, is understood to be within the range of physiological response to stress in daily life. However, frequent episodes may cause disability that sometimes requires expensive drugs and prophylactic medication.
    [Show full text]
  • Vascular Surgery for Chronic Migraine
    RESEARCH ARTICLE Vascular surgery for chronic migraine Elliot Shevel Background: The superficial branches of the external carotid artery have been shown to The Headache Clinic, Suite 243, Private Bag be the origin of headache pain in some individuals. Surgical ligation of the temporal X2600, Houghton 2041, artery was first described by Al Zahrawi. Since then, excellent results have been achieved South Africa surgically in those patients in whom the superficial vessels have been positively identified Tel.: +27 114 840 933; Fax: +27 114 824 167; as the source of the headache pain. Aim: To determine the improvement in quality of life E-mail: drshevel@ in patients suffering from chronic daily headache (CDH) following cauterization of headclin.com superficial scalp vessels. Patients & methods: In total, 65 patients with CDH, in whom the superficial scalp vessels were positively identified as the source of pain, underwent surgical cauterization of the relevant vessels. Results: The quality of life of CDH sufferers in whom the pain was shown to originate in the superficial scalp vessels was significantly improved following surgical cauterization of the relevant vessels. Conclusion: Surgical cauterization of superficial scalp vessels can be a valuable treatment modality in selected patients with CDH. The extracranial branches of the external carotid revised criteria [31], and in whom there was a pos- artery are an important source of pain in some itive diagnosis of extracranial arterial pain, were patients with primary headaches [1–16]. In these included in the study. The subjects were patients, surgical cauterization of the relevant recruited from patients attending The Headache arteries provides permanent pain relief [17–26].
    [Show full text]